Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures
- 1 February 2001
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 23 (2) , 292-306
- https://doi.org/10.1016/s0149-2918(01)80012-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIsPharmacoEconomics, 2000
- Use of Antidepressants Among Elderly Subjects: Trends and Contributing FactorsAmerican Journal of Psychiatry, 2000
- Fortnightly review: Drug treatment of depressionBMJ, 1999
- Course of Antidepressant Treatment, Drug Type, and Prescriber's SpecialtyPsychiatric Services, 1998
- The Pharmacologic Treatment of DepressionThe Journal of the American Board of Family Medicine, 1998
- Prescribing Trends in Psychotropic MedicationsJAMA, 1998
- Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysisJournal of Affective Disorders, 1998
- Initial antidepressant choice in primary care. Effectiveness and cost of fluoxetine vs tricyclic antidepressantsPublished by American Medical Association (AMA) ,1996
- Patterns of antidepressant use in community practiceGeneral Hospital Psychiatry, 1993
- Adequacy and Duration of Antidepressant Treatment in Primary CareMedical Care, 1992